Gov. Dannel Malloy announced on Tuesday that Alexion Pharmaceuticals, a multibillion-dollar drug company, will relocate its headquarters to New Haven’s planned Downtown Crossing development at 100 College St. with financial assistance from the state — adding hundreds of jobs to the Elm City. Malloy’s announcement marks the state’s latest bid to foster biotechnology and medical »
After nearly a month-long delay, Downtown Crossing, the city’s largest redevelopment effort in a generation, is back on track for a vote by the full full Board of Aldermen. At a public hearing Thursday night held by the joint finance and legislation committee, aldermen heard opinions from community members on the zoning changes and the »
The 2003 firefighter promotions exam that sparked a Supreme Court lawsuit and national controversy is continuing to cause legal headaches for the city. Though New Haven asked the Supreme Court to revisit the matter in hopes of ending the saga, the Court decided Monday to stay out of it. In 2003, the city administered a »
Downtown Crossing, the city’s $135 million project to remake downtown that stalled in the Board of Aldermen last month, is nearly back on track. The City Plan Commission voted on Wednesday vote to approve a zoning change that would convert 15.8 acres of land from New Haven’s central business district into a new mixed-use district »
State Attorney General George Jepsen announced on Friday that he will not seek to block the proposed acquisition of the Hospital of Saint Raphael by the Yale-New Haven Hospital — clearing the way for the Elm City’s two major hospitals to merge. Jepsen’s announcement follows the conclusion of his antitrust investigation, coordinated with the Federal »